![ALS Therapy Developer NMD Pharma Obtains $47 Million in New Financing | Call center, Negotiation skills, Therapy ALS Therapy Developer NMD Pharma Obtains $47 Million in New Financing | Call center, Negotiation skills, Therapy](https://i.pinimg.com/736x/98/0f/74/980f745daf3a9f47efac3fe2adc34efc.jpg)
ALS Therapy Developer NMD Pharma Obtains $47 Million in New Financing | Call center, Negotiation skills, Therapy
![NMD Pharma Raises $39.7 Million to Advance Pipeline Targeting Rare Neuromuscular Disorders - Global Genes NMD Pharma Raises $39.7 Million to Advance Pipeline Targeting Rare Neuromuscular Disorders - Global Genes](https://globalgenes.org/wp-content/uploads/2022/02/Thomas-Holm-Pedersen-NMD.jpg)
NMD Pharma Raises $39.7 Million to Advance Pipeline Targeting Rare Neuromuscular Disorders - Global Genes
![Jeito Capital Becomes Key Investor in NMD Pharma as Part of a €35 Million New Financing | Business Wire Jeito Capital Becomes Key Investor in NMD Pharma as Part of a €35 Million New Financing | Business Wire](https://mms.businesswire.com/media/20220214005583/en/1358538/23/JEITO-04_%281%29.jpg)
Jeito Capital Becomes Key Investor in NMD Pharma as Part of a €35 Million New Financing | Business Wire
![NMD pulls in $40M from Jeito-led, Roche-backed syndicate, gaining financial muscle to crack myasthenia gravis market | Fierce Biotech NMD pulls in $40M from Jeito-led, Roche-backed syndicate, gaining financial muscle to crack myasthenia gravis market | Fierce Biotech](https://qtxasset.com/cdn-cgi/image/w=384,h=216,f=auto,fit=crop,g=0.5x0.5/https://qtxasset.com/quartz/qcloud5/media/image/fiercebiotech/1641490642/GettyImages-866149824%20%281%29.jpg/GettyImages-866149824%20%281%29.jpg?VersionId=lm.pi47bTRA.WNeogYiEG7XzDbOWaYme)
NMD pulls in $40M from Jeito-led, Roche-backed syndicate, gaining financial muscle to crack myasthenia gravis market | Fierce Biotech
![Novo Seeds portfolio company NMD Pharma reports positive top-line Phase I/IIa data in myasthenia gravis - Startup Weekly Novo Seeds portfolio company NMD Pharma reports positive top-line Phase I/IIa data in myasthenia gravis - Startup Weekly](https://startup-weekly.com/connectors/images/Novo%20Seeds-StartupWeekly%20.png)